157 Radical radiotherapy for NSCLC in the very elderly: Can failure to tolerate treatment be predicted?
Sonali Chaudhury(Northwestern University), L. Pemberton, H. Lander, Andrew McPartlin, A. Chittalia, J. Coote, L. Lee, N. Bayman, P.A. Burt, R. Swindell, Margaret Harris, H. Sheikh, Corinne Faivre‐Finn(University of Manchester)
Cited by 0
Related Papers
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
|New England Journal of Medicine|2007|1.1k
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
|Annals of Oncology|2020|313
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
|Transplantation and Cellular Therapy|2013|248
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
|Radiotherapy and Oncology|2020|227